Clinical Trials in Pennsylvania

Showing 13981-14000 of 16,895 trials

ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

NCT01154426

This phase I trial is studying the side effects and best dose of giving ABT-888 together with gemcitabine hydrochloride in treating patients with advanced solid tumors. ABT-888 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving ABT-888 together with gemcitabine hydrochloride may kill more tumor cells.

Adult Solid NeoplasmBRCA1 Mutation CarrierBRCA2 Mutation Carrier

National Cancer Institute (NCI)31 participantsStarted May 2010

Hershey, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 356 miles

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

NCT00073021

This study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis. In addition, a new tablet formulation will be evaluated at one of the two doses.

Ulcerative Colitis

Warner Chilcott386 participantsStarted Sep 2000

Scottsdale, Arizona, United States • Anaheim, California, United States • Los Angeles, California, United States +54 more locations

ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Find Trials by Condition in Pennsylvania

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

MANAGE Automated Glucose Monitoring

Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150